While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...
Dr. Pankaj Arora, MD, FAHA, is a physician scientist in the Division of Cardiovascular Disease with expertise in the human genetics and genomics of complex cardiovascular traits, as well as ...
"[The study] findings suggest that, among people with obesity and a high cardiovascular risk, a NT-pro BNP [NT-proBNP] < 125 pg/mL may not rule out the presence of HF," the researchers of the study ...
Natriuretic peptides are hormones with a range of key functions vital for regulating cardiometabolic health, including regulating blood pressure, blood sugar levels, and increasing utilization of ...
Portugal: Researchers have found in a new study that obesity may mask heart failure by lowering NT-proBNP levels. Obesity was ...
The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.
Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...
Luís Beck-da-Silva, MD; Adolfo de Bold, PhD, FRSC; Ross A. Davies, MD, FRCPC; Benjamin J.W. Chow, MD, FRCPC; Terrence D. Ruddy, MD, FRCPC; Margaret Fraser, RN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results